Mixed dementia — when it's more than one thing

This article is for educational purposes only and does not constitute medical, legal, or financial advice. Every family situation is different, and you should consult with appropriate professionals about your specific circumstances.

Your neurologist uses the word promising. Your mother's memory loss might respond to medication. It might slow the decline. There might be some benefit. You're hearing these words through hope, but underneath the hope is the dread of a harder question: will it work? Will she get better? What exactly are we looking at here?

Let me be straight with you. There is no dementia medication that reverses cognitive loss. There's no pill that gives your parent's memory back. That's not how these drugs work, and if someone's implying they do, they're selling you something false. What actually exists are medications that might slow the rate of decline and might manage some of the symptoms that make dementia harder to live with. The word might appears in almost every sentence for a reason. We're talking about modest benefits, not transformation.

This is a conversation you need to have with clear eyes. Because choosing to put your parent on dementia medication is not a simple medical decision. It's a family conversation about what matters, what you're hoping for, what you're willing to do, and what the trade-offs look like. The medication might help. It might not. But it will definitely come with side effects that you'll have to manage.

The Honest Answer

There are currently no disease-modifying treatments for Alzheimer's disease that stop the progression of cognitive decline. Let me say that one more time because it's important and it's easy to mishear: these medications do not stop the disease from progressing. They do not reverse damage that's already happened.

What they might do is slow the rate of decline. And slow means slow. We're talking about delaying cognitive loss by months, not years. If your parent's untreated cognitive decline was following a particular trajectory, a medication might make that trajectory slightly less steep. The difference between losing significant function in twelve months versus eighteen months. The difference between moderate and severe dementia being reached six months later than it otherwise would be.

That matters to some families and doesn't matter to others. You have to decide, in your specific situation, whether six months of delay is worth the effort and the side effects and the medical appointments and the hope that comes with taking something and the disappointment when that something doesn't deliver the miracle you were secretly hoping for.

What symptoms these medications might help with varies. Some people on medications report better attention and focus. Some people's behavioral problems improve slightly. Some people experience clearer moments or less confusion. Others notice no difference at all. There's no way to predict in advance who will benefit and who won't. You basically have to try it and see what happens.

What Exists

The older class of medications used for dementia are cholinesterase inhibitors. These include donepezil, rivastigmine, and galantamine. They work by preventing the breakdown of acetylcholine, a neurotransmitter involved in memory and attention. When you lose brain cells to Alzheimer's, the cholinesterase inhibitors help the remaining cells function more efficiently. The benefit is modest and temporary, but for some people it's something.

There's also memantine, which works on a different neurotransmitter system called glutamate. Memantine can be used alone or combined with cholinesterase inhibitors. It's often prescribed in the later stages of Alzheimer's when the cholinesterase inhibitors are less effective.

And then there are the newer monoclonal antibody drugs that have generated a lot of attention recently. These medications target amyloid beta, one of the abnormal proteins that accumulates in Alzheimer's disease. These are drugs like aducanumab, lecanemab, and donanemab. The idea is that by clearing amyloid, the disease progression might be slowed even more than the older medications could manage.

This is where you're hearing the word promising most often. These newer drugs do show a slightly greater slowing of decline compared to the older medications. But they come with their own risks, including something called amyloid-related imaging abnormalities, which is a fancy way of saying brain imaging shows evidence of inflammation or microhemorrhages. For some people this causes no symptoms. For others it causes cognitive problems or headaches or other issues.

Each of these medication classes has different effectiveness profiles in different stages of dementia. What works well in early stages might be ineffective later. Combinations might work better than single medications for some people. The evidence is constantly evolving as researchers continue to study how these drugs affect the disease.

What They Actually Do

If your parent starts a dementia medication, the most likely outcome is that they will continue to decline cognitively, but the decline might be slightly slower than it would have been without the medication. They will still lose memory. They will still lose function. They will still experience the cognitive and behavioral symptoms of dementia. The medication doesn't treat the disease itself. It just slightly reduces how quickly the disease progresses.

Think about it this way: if your parent was going to progress from mild cognitive impairment to moderate dementia in two years without medication, with medication they might make that transition in two and a half years. That's the scale we're talking about. It's not the progression stopping. It's not major delay. It's a slower slope on a graph that was already trending downward.

Some families find this valuable. Six more months of them being more themselves. Six more months of clearer thinking. Six more months before they need a different level of care. Six more months of conversations that make more sense. That might be worth it to you.

For other families, the side effects and the medical appointments and the complexity of managing another medication outweigh a six-month delay in decline. There's no wrong answer here. It depends entirely on your situation.

What these medications can also do is manage some of the non-cognitive symptoms that come with dementia. Behavioral problems, agitation, mood changes, sleep disturbances—these sometimes respond to medication. Not the actual memory loss. Not the personality changes that come from the disease itself. But the agitation and the pacing and the sundowning. If your parent is driving everyone crazy because they're agitated, medication can sometimes help. That's not slowing the disease. That's making the disease more manageable for everyone involved.

Side Effects

Here's what gets minimized in a lot of medical conversations: these medications have real side effects, and your parent is going to have to tolerate them.

Cholinesterase inhibitors commonly cause nausea, vomiting, diarrhea, and loss of appetite. These tend to be worse when starting the medication and might improve over time, but they might not. Some people on these medications lose weight because the nausea makes eating difficult. Some people become physically ill from the digestive side effects.

There can be dizziness and fainting, which in someone already at risk for falls is a serious problem. Falls in older people lead to fractures and head injuries and everything downstream from that. You're weighing a possible slight slowing of cognitive decline against a real increased risk of falls.

Heart problems can occur with some of these medications. Changes in heart rate, bradycardia, syncope. If your parent already has heart issues, this is a real consideration.

Memantine can cause dizziness, confusion, and constipation. It can make agitation worse in some people before it makes it better.

The newer antibody drugs come with the risk of amyloid-related imaging abnormalities. That sounds abstract until you read that it means microhemorrhages in the brain. Your parent might be fine with no symptoms. Or they might have cognitive problems or neurological symptoms from the medication that's supposed to help their cognitive problems. That's a specific kind of cruel irony.

There are also the logistics of these medications. Some require monthly infusions. Some require regular MRI imaging to check for safety issues. Some require blood work. You're committing to ongoing medical appointments and monitoring, and you're hoping that the modest benefit is worth the ongoing effort.

The Decision

Whether to medicate is a genuine family conversation, not something your doctor should be deciding alone and certainly not something you should decide without understanding what you're actually choosing.

The questions to ask are these: What is your parent's current functional level? How much time do you have with them likely left? What would six months of slower cognitive decline actually mean for your family? What's your parent's general health like? How likely are they to experience the side effects? How much medical management can you realistically handle? What does your parent want, if they're able to tell you?

Sometimes the answer is to try medication and see what happens. You start your parent on a medication, you monitor them carefully for side effects, you wait to see if they seem more clear or function better, and you decide after a few months whether it's worth continuing. That's reasonable.

Sometimes the answer is to decline medication and focus on quality of life instead. To skip the appointments and the side effects and the hope that comes with taking something and just work on making your parent comfortable in whatever time you have. That's reasonable too.

Sometimes the answer is somewhere in between. You might use medication to manage agitation or behavioral problems without trying the medications that slow cognitive decline. You might try a medication for a set period of time and then reassess. You might use a medication combined with non-pharmaceutical approaches like cognitive therapy or physical activity.

What matters is that you're making an informed choice that reflects your family's values and your parent's actual best interests, not the hope that medicine will restore what's been lost. It won't. But it might help at the margins. Whether helping at the margins is worth the effort and the side effects is a question only you can answer.

Your parent's neurologist can tell you what the evidence shows. But you're the one living in this situation. You're the one figuring out what matters and what the trade-offs look like. Take your time with this decision. It doesn't have to be made quickly. Talk to your parent if they can understand the conversation. Talk to siblings if you have them. Get a second opinion if you want one. And then make the choice that feels right for your family, knowing that there's no perfect choice here. There's just the choice you make and the reasons you make it.

How To Help Your Elders is an educational resource. We do not provide medical, legal, or financial advice. The information in this article is general in nature and may not apply to your specific situation. If you are concerned about medication options for your loved one's cognitive decline, consult with their healthcare provider for personalized medical advice and guidance based on their individual circumstances.